08
October 2024
Past Event
Do Drug Patents Cause High Drug Prices?

Event will air on this page.

 

Inquiries: msnow@hudson.org

Do Drug Patents Cause High Drug Prices?

Past Event
Online Only
October 08, 2024
Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024. (Spencer Platt via Getty Images)
Caption
Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024. (Spencer Platt via Getty Images)
08
October 2024
Past Event

Event will air on this page.

 

Inquiries: msnow@hudson.org

Speakers:
Adam Mossoff
Adam Mossoff

Chair, Forum for Intellectual Property and Senior Fellow

William H. Pittman Professor of Law and Timothy J. Heinsz Professor of Law, University of Missouri School of Law
Erika Lietzan

William H. Pittman Professor of Law and Timothy J. Heinsz Professor of Law, University of Missouri School of Law

Vice President and Global Head of Intellectual Property Affairs, Novartis
Corey A. Salsberg

Vice President and Global Head of Intellectual Property Affairs, Novartis

Moderator:
hartline
Devlin Hartline

Senior Fellow

For the past decade, policy activists have argued that drug innovators artificially extend the length of their exclusive patent protections on their drugs solely to keep drug prices high. One activist organization, the Initiative for Medicines, Access, and Knowledge (I-MAK), alleges that as many as 50 patents currently protect drugs from generic competition. 

But are I-MAK’s patent numbers correct? A 2022 Hudson policy memo, “How Unreliable Data Has Infected the Policy Debate Over Drug Patents,”detailed how I-MAK’s patent numbers contradict the number of drug patents listed in the Orange Book, the Food and Drug Administration’s official database of drug patents. Academic scholars have also done rigorous empirical studies, and the United States Patent and Trademark Office (USPTO) released its own empirical study in June 2024. Neither the USPTO nor the academic studies could replicate or confirm activist organizations’ patent numbers. Yet I-MAK’s claims continue to drive legislative proposals and agency actions.

Join Hudson for an expert discussion on the state of play concerning the empirical evidence on the connection between drug patents and drug prices and whether officials are engaging in evidence-based policymaking on this pressing concern.

Related Events
11
November 2026
Virtual Event | Hudson Institute
A US Navy Fleet for Twenty-First-Century Deterrence and Combat
Featured Speaker:
Bryan Clark
Skipper
11
November 2026
Virtual Event | Hudson Institute
A US Navy Fleet for Twenty-First-Century Deterrence and Combat

Join Senior Fellow Bryan Clark for a presentation of his new report, Righting the Ship: Building a Relevant US Navy Fleet for Twenty-First-Century Deterrence and Combat. He will discuss the challenges facing the US Navy and how a new fleet design could help it address its missions within likely future budget and personnel constraints. The webinar will also include time for questions and answers.

Skipper
Featured Speaker:
Bryan Clark
12
November 2026
In-Person Event | Hudson Institute
From Dependence to Resilience: Financing a Secure Pharmaceutical Supply Chain
Featured Speakers:
Caroline Vik
Maryll Toufanian
Nick Snyder
Pharma
12
November 2026
In-Person Event | Hudson Institute
From Dependence to Resilience: Financing a Secure Pharmaceutical Supply Chain

Join DFC Chief Policy Officer Caroline Vik and Amneal Pharmaceuticals Senior Vice President Maryll Toufanian for a conversation moderated by Senior Fellow Nick Snyder. The discussion will examine America’s strategy to secure pharmaceutical supply chains and the work ahead for policymakers and industry as they pursue sustainable solutions in a complex market and policy environment. 

Pharma
Featured Speakers:
Caroline Vik
Maryll Toufanian
Nick Snyder
13
November 2026
In-Person Event | Invite Only
The Future of US-Japan Cooperation in a Competitive World: Economic Security and Strategy
Featured Speakers:
Nick Snyder
Hiroyuki Nakashima
Takaichi
13
November 2026
In-Person Event | Invite Only
The Future of US-Japan Cooperation in a Competitive World: Economic Security and Strategy

Join Japan Bank for International Cooperation Senior Managing Director Hiroyuki Nakashima and Senior Fellow Nick Snyder for a conversation on the state of the US-Japan relationship, the links between economic cooperation and national security, and the opportunities and challenges ahead for the alliance.

Takaichi
Featured Speakers:
Nick Snyder
Hiroyuki Nakashima
13
November 2026
In-Person Event | Hudson Institute
Putting Veterans First: A Conversation with Secretary of Veterans Affairs Doug Collins
Featured Speakers:
Doug Collins
Jeremy Hunt
Collins
13
November 2026
In-Person Event | Hudson Institute
Putting Veterans First: A Conversation with Secretary of Veterans Affairs Doug Collins

Two days after Veterans Day, United States Secretary of Veterans Affairs Douglas Collins will deliver a keynote address on the Department of Veterans Affairs’ work and his plans under President Donald Trump. He will also join Hudson Institute fellow Jeremy Hunt for a fireside chat.

Collins
Featured Speakers:
Doug Collins
Jeremy Hunt